1. Extracellular matrix and its therapeutic potential for cancer treatment
   Jiacheng Huang et al, 2021, Signal Transduction and Targeted Therapy CrossRef
2. Multilevel regulation of Wnt signaling by Zic2 in colon cancer due to mutation of β-catenin
   Zhengshui Xu et al, 2021, Cell Death & Disease CrossRef
3. Prognostic Value of LGR5 in Colorectal Cancer: A Meta-Analysis
   Qing Chen et al, 2014, PLoS ONE CrossRef
4. Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies
   Zihao Wu et al, 2024, International Journal of Molecular Sciences CrossRef
5. Cancer stem cells - a brief overview
   J Sam Vijay Kumar, 2016, Annals of SBV CrossRef
6. Cancer Stem Cells and Circulating Tumor Cells: Molecular Markers, Isolation Techniques, and Clinical Implications
   Ebrahim Azizi et al, 2016, Circulating Tumor Cells CrossRef
7. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: A meta-analysis
   Ye Han et al, 2015, Clinics and Research in Hepatology and Gastroenterology CrossRef
8. Leucine‑rich repeat‑containing G protein‑coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer
   Yuzo Harada et al, 2017, Oncology Letters CrossRef
9. Prognostic impact of doublecortin‐like kinase 1 expression in locally advanced rectal cancer treated with preoperative chemoradiotherapy
   Yuzo Harada et al, 2018, APMIS CrossRef
10. Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review
    Marzia Mare et al, 2021, Genes CrossRef
11. Epigenetic Mechanisms of Colon Cancer Prevention: What Can Nutrition Do?
    Yuan-Xiang Pan et al, 2014, Molecular mechanisms and physiology of disease CrossRef
12. Stem Cell Signaling Pathways in Colorectal Cancer
    B. S. Ramakrishna et al, 2013, Current Colorectal Cancer Reports CrossRef
13. Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
    M Ozawa et al, 2014, British Journal of Cancer CrossRef
14. Cancer stem cells in human digestive tract malignancies
    Fatemeh B. Rassouli et al, 2016, Tumor Biology CrossRef
15. Still proliferating CD44+/Ki67+ tumor cells after neoadjuvant radiochemotherapy identify rectal cancer patients with poor survival
    Johannes Klose et al, 2021, European Journal of Surgical Oncology CrossRef
16. CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis
    Hiroshi Nagata et al, 2018, International Journal of Oncology CrossRef
17. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
    Yangyan Jiang et al, 2015, BMC Cancer CrossRef
18. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis
    Yangyan Jiang et al, 2016, BMC Cancer CrossRef
19. Telomere Maintenance-Associated PML Is a Potential Specific Therapeutic Target of Human Colorectal Cancer
    Peng Gong et al, 2019, Translational Oncology CrossRef
20. Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy
    Rena Morita et al, 2016, Clinical Cancer Research CrossRef
21. WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice
    Vijay Pratap Singh et al, 2017, BMC Cancer CrossRef
22. Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer
    HONG-QING XI et al, 2014, Oncology Reports CrossRef
23. CD44 Standard Isoform; Not a Good Marker for Colon Cancer
    Pantea Rohani et al, 2017, International Journal of Cancer Management CrossRef
24. The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
    Zhenpeng Wang et al, 2019, Frontiers in Oncology CrossRef